ATE80162T1 - Antibiotisch wirkende isoxazolderivate, ihre herstellung und verwendung. - Google Patents

Antibiotisch wirkende isoxazolderivate, ihre herstellung und verwendung.

Info

Publication number
ATE80162T1
ATE80162T1 AT85309197T AT85309197T ATE80162T1 AT E80162 T1 ATE80162 T1 AT E80162T1 AT 85309197 T AT85309197 T AT 85309197T AT 85309197 T AT85309197 T AT 85309197T AT E80162 T1 ATE80162 T1 AT E80162T1
Authority
AT
Austria
Prior art keywords
antibiotic
production
isoxazole derivatives
amino
hydrogen
Prior art date
Application number
AT85309197T
Other languages
English (en)
Inventor
Koichi Yoshioka
Setsuo Harada
Michihiko Ochiai
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1984/000602 external-priority patent/WO1986003752A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE80162T1 publication Critical patent/ATE80162T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/65392—Five-membered rings containing two nitrogen atoms
    • C07F9/65395—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
AT85309197T 1984-12-18 1985-12-17 Antibiotisch wirkende isoxazolderivate, ihre herstellung und verwendung. ATE80162T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/JP1984/000602 WO1986003752A1 (en) 1984-12-18 1984-12-18 Novel antibiotic derivatives, process for their preparation and use thereof
PCT/JP1985/000358 WO1987000178A1 (en) 1984-12-18 1985-06-25 Novel antibiotic derivatives, process for their preparation, and use thereof
JP19507585 1985-09-04
JP25318885 1985-11-11
EP85309197A EP0191989B1 (de) 1984-12-18 1985-12-17 Antibiotisch wirkende Isoxazolderivate, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ATE80162T1 true ATE80162T1 (de) 1992-09-15

Family

ID=26508902

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85309197T ATE80162T1 (de) 1984-12-18 1985-12-17 Antibiotisch wirkende isoxazolderivate, ihre herstellung und verwendung.

Country Status (10)

Country Link
EP (1) EP0191989B1 (de)
JP (1) JPH0674275B2 (de)
CN (1) CN1024668C (de)
AT (1) ATE80162T1 (de)
DE (1) DE3586591T2 (de)
DK (1) DK558885A (de)
ES (1) ES8705431A1 (de)
HU (1) HU204266B (de)
IE (1) IE59102B1 (de)
WO (1) WO1987000178A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63107977A (ja) * 1986-05-21 1988-05-12 Takeda Chem Ind Ltd イソオキサゾロン誘導体
JPS63107978A (ja) * 1986-06-12 1988-05-12 Takeda Chem Ind Ltd イソキサゾリジノン誘導体およびその製造法
US4882434A (en) * 1986-10-29 1989-11-21 Takeda Chemical Industries, Ltd. Gamma-lactonecarboxylic acid derivatives and their use as antibacterial agents or intermediates
WO2006009907A2 (en) * 2004-06-17 2006-01-26 Infinity Pharmaceuticals, Inc. Isoxazolidine compounds for treatment of bacterial infections
CN108440510A (zh) * 2017-02-16 2018-08-24 南京正荣医药化学有限公司 一种酰胺类杀菌剂

Also Published As

Publication number Publication date
EP0191989A1 (de) 1986-08-27
DK558885A (da) 1986-06-19
ES550040A0 (es) 1987-05-01
JPH0674275B2 (ja) 1994-09-21
IE59102B1 (en) 1994-01-12
ES8705431A1 (es) 1987-05-01
HU204266B (en) 1991-12-30
DE3586591D1 (de) 1992-10-08
IE853198L (en) 1986-06-18
CN1024668C (zh) 1994-05-25
JPS62201887A (ja) 1987-09-05
DE3586591T2 (de) 1993-01-21
DK558885D0 (da) 1985-12-03
CN85109633A (zh) 1987-01-07
HUT41773A (en) 1987-05-28
EP0191989B1 (de) 1992-09-02
WO1987000178A1 (en) 1987-01-15

Similar Documents

Publication Publication Date Title
ATE129498T1 (de) Kondensierte heterozyklische verbindungen, ihre herstellung und verwendung.
AU1353988A (en) 1,4-disubstituted piperazine compounds, their production and use
DE3588100D1 (de) Carbamidsäureester-Derivate, Mittel und Herstellungsverfahren
DE68920796T2 (de) Chinolinderivate, ihre Herstellung und Verwendung.
IL91474A0 (en) Spiro compounds and their production
ZA93267B (en) Novel arylcyloakyl derivatives their production and their use
ATE53585T1 (de) Penemverbindungen, ihre herstellung und verwendung.
ATE238298T1 (de) Tetraderivate, ihre herstellung und verwendung
FI935830A0 (fi) Bicykliska aminderivat
NO304833B1 (no) Nye pyrrolokarbazoler
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
DE69024397T2 (de) Diaminoethylen-Verbindungen
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
ES2046229T3 (es) Composicion antiulcerosa.
ATE80162T1 (de) Antibiotisch wirkende isoxazolderivate, ihre herstellung und verwendung.
ATE85978T1 (de) 2-quaternaer-pyridinalkylthio- oder pyridinalkenylthiosubstituierte carbapeneme, diese enthaltende zusammensetzungen und ihre zusammenstellungen mit dhp-inhibitoren.
DE3876712D1 (de) Antianaerobe naphthyridinverbindungen.
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
AU567867B2 (en) 5(e)-13,14,18,18,19,19-hexahydro-6a-carbaprostaglandin 12 derivatives
ES8801650A1 (es) Un metodo para preparar derivados de acido (2-amino sustutuido-3-oxo-2-isoxazolidinil)-5-oxo-2-tetrahidrofuran-carboxilico.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties